The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients

Despite current standards of care aimed at achieving targets for low-density lipoprotein (LDL) cholesterol, blood pressure and glycaemia, dyslipidaemic patients remain at high residual risk of vascular events. Atherogenic dyslipidaemia, specifically elevated triglycerides and low levels of high-dens... View More